Romy Injection belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Immune thrombocytopenia, often called idiopathic thrombocytopenic purpura (ITP), is an immune disorder characterised by low platelet counts.
Romy Injection contains 'Romiplostim,' which is a thrombopoietin receptor agonist that functions similarly to thrombopoietin. Romy Injection promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romy Injection helps treat immune thrombocytopenia effectively.
Romy Injection will be administered by the healthcare professional. In some cases, Romy Injection may cause common side effects like headache, joint pain, dizziness, trouble sleeping, muscle tenderness or weakness, pain in the arms and legs and indigestion. These side effects may vary individually. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Notify your doctor if you have allergic reactions to Romy Injection or other medications. You must inform your doctor if you have leukaemia (blood or bone marrow cancer), bleeding or clotting disorders, or heart, kidney, or liver problems. Romy Injection is not recommended during pregnancy unless indicated by the doctor. Romy Injection may make you dizzy; hence drive or operate machinery only when you are alert. Romy Injection is not recommended for use during breastfeeding.